Navigation Links
Medicsight Announces Global Agreement With Alma IT Systems
Date:6/25/2009

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (NYSE AMEX: MGT) and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, which assists radiologists in the early detection of disease, is pleased to announce it has signed a non-exclusive, software license and distribution agreement with Alma IT Systems ("Alma"). Alma is a leading developer of advanced digital medical imaging tools, across Europe and South America. This agreement will give Medicsight access to Alma's large and established installed base of radiology customers in key markets.

As part of this agreement Medicsight's ColonCAD API 4.0 software will be integrated into Alma's latest Colon viewer, a 3D visualization workstation which interprets computed tomographic colonography (CTC) image data. Alma is one of Spain's market leaders in medical imaging technology. It is anticipated that the new product will be offered to both clinicians and PACS customers via the ALMA 3D workstation and server-based client platforms.

Commenting on the partnership, Jacobo Gil de Biedma, co-founder and CEO of Alma IT Systems, said, "Alma is a market leader in medical imaging software in Spain and we are quickly gaining market share in Europe and South America. We are seeing a growing demand for CT colonography imaging tools. By developing the latest Alma Colon viewer with the integration of Medicsight's latest ColonCAD application, we can offer our clients complete, fast and reliable imaging technology and continue to consolidate the ALMA 3D platform as a one-stop solution."

Allan Rowley, Chief Executive of Medicsight, commented, "This agreement provides Medicsight with an ideal commercial opportunity to work with Alma and further extend our reach into the European and South American medical imaging markets. We look forward to the swift roll out of the integrated technology."

The prototype Alma 3D Colon viewer is available for demonstration on the Medicsight booth (number 13) at the 20th Annual European Society of Gastrointestinal and Abdominal Radiology (ESGAR 2009) taking place this week in Valencia.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange Ltd.

Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerized tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software products are seamlessly integrated with the advanced 3D visualization workstations of several industry-leading imaging equipment partners.

Medicexchange Ltd. provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.


'/>"/>
SOURCE MGT Capital Investments, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CMS Decision - No Material Financial Impact to Medicsight
2. Medicsight PLC Provides Business Update
3. Medicsight PLC Restructures Management Team
4. MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding CMS Proposed Decision
5. Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance
6. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
7. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
8. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
9. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
10. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
11. Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Ongoing news ... Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer look ... released today illustrates the prevalence and causes of TBI among the aging population, and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a ... for the fourth quarter and full year ended December 31, 2015 on Monday, February ... and webcast for the investment community following the release at 4:30 PM ET. Investors ...
(Date:2/10/2016)... ... ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves with age, ... Guide to Brain Training" by award-winning author Phyllis Strupp explains how brain ... 16, 2016. A free review copy is available to the media at NetGalley ...
(Date:2/10/2016)... ... 2016 , ... IDEX Health & Science, LLC announces the ... columns combine the strength of traditional stainless steel with the chemical inertness of ... operating at ultra-high pressures of 20,000 psi. The higher operating pressures allow faster ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... The recreational ... cannabis enthusiasts in the state still face a lot of restrictions as to where ... is intended for private, personal use” and that cannabis “may not be consumed openly ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Health, Inc. (Nasdaq: GHDX ) today reported financial results ... 2015. --> --> Revenue was ... million in the fourth quarter of 2014, an increase of 8 ... with the same period in the prior year. ... the fourth quarter of 2015, an increase of 9 percent compared ...
(Date:2/10/2016)... LEXINGTON, Massachusetts , February 10, 2016 --> ... Japan .  --> Japan .  ... Japan .  With submission, Shire continues to ... --> With submission, Shire continues to ... With submission, Shire continues to strengthen ...
(Date:2/10/2016)... and SAN DIEGO , Feb. ... a global leader in viral gene therapy manufacturing, and ... for congestive heart failure and other chronic diseases, have ... scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug ... --> --> This ...
Breaking Medicine Technology: